Watch Ticker

Protagonist Therapeutics, Inc

Go to Protagonist Therapeutics, Inc Website

$53.90

0.00 (0.00%)

Live

Previous Close

$53.9

Day Range

$0 - $0

Previous Day Range

$52.03 - $54.3275

Market Cap

$3.3 billion USD

Day Vol.

Previous Day Vol.

460694

Currency

USD

Primary Exchange

Nasdaq

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer

Protagonist Therapeutics and Takeda Pharmaceutical's investigational drug rusfertide met its primary endpoint in a late-stage study for polycythemia vera, a type of blood cancer. The drug showed a significantly higher proportion of clinical responders compared to placebo.

Related tickers: PTGX, TAK.

Read Full Article

Delveinsight - BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment

BESREMi, a FDA-approved treatment for polycythemia vera, is gaining market share due to its potential for better tolerability and lower risk of treatment-related malignancies compared to competitors like ruxolitinib and hydroxyurea.

Related tickers: NVS, PTGX, IONS, MRK, SLN, ABBV, BMY, CELGr, GSKH.

Read Full Article

Trending Tickers

Please sign in to view